Fellow

Dr. David Gruber is currently the Managing Director and Director of Research with Alvarez & Marsal Healthcare Industry Group (HIG) in New York, specializing in strategy, business development, consumer engagement, innovation, new ventures, technology, analytics, and health benefits. He is currently responsible for thought leadership and model development within HIG, co-leads A&M health benefit activities and is involved in a wide range of consulting projects. Dr. Gruber brings 30 years of diversified healthcare experience as a consultant, corporate executive, Wall Street analyst and physician. Before A&M, he spent three years as the Founder of Healthcare Convergence Associates, a consulting firm focused on the convergence of healthcare, technology and the consumer.

Until December 2008, Dr. Gruber was Vice President, Corporate Development and New Ventures, J&J Consumer Group of Companies. Between 1995-2004, Dr. Gruber worked on Wall Street as a top-ten rated analyst at Lehman Brothers and elsewhere covering medical device and supply companies. He was the lead analyst for the Intuitive Surgical and Given Imaging IPOs, as well as a merchant banking investment in Therasense. Prior to entering Wall Street, Dr. Gruber was Vice President, Planning & Business Development, Healthcare Group at Bristol-Myers Squibb. 

Dr. Gruber is a magna cum laude graduate of a six-year BS-MD program, having received his BS from CCNY and his MD from the Mt. Sinai School of Medicine. He also has an MBA from Columbia, and was a Kellogg Foundation National Fellow.